Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Kobayashi Pharmaceutical Co (FRA:KOY) Forward PE Ratio Explanation
The Forward PE Ratio of a company is often used to compare current earnings to estimated future earnings, as well as gaining a clearer picture of what earnings will look like without charges and other accounting adjustments. If earnings are expected to grow in the future, the Forward PE Ratio will be lower than the current PE Ratio. This measure is also used to compare one company to another with a forward-looking focus.
Trailing PE Ratio relies on what is already done. It uses the current share price and divides by the total EPS (Basic) over the past 12 months. PE Ratio can be affected by Non Operating Income such as the sale of part of businesses. This may increase for the current year or quarter dramatically. But it cannot be repeated over and over. Therefore PE Ratio without NRI is a more accurate indication of valuation than PE Ratio .
Kobayashi Pharmaceutical Co Forward PE Ratio Related Terms
Kobayashi Pharmaceutical Co Forward PE Ratio Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Kobayashi Pharmaceutical Co Forward PE Ratio Chart
Kobayashi Pharmaceutical Co Annual Data
Trend
2024-12
2025-12
Forward PE Ratio
26.74
26.65
Kobayashi Pharmaceutical Co Quarterly Data
2018-03
2024-12
2025-03
2025-06
2025-09
2025-12
2026-03
Forward PE Ratio
30.03
26.74
28.71
30.95
27.13
26.65
34.26
FRA:KOY vs PG, CL, KVUE: Forward PE Ratio Comparison
For the Household & Personal Products subindustry, Kobayashi Pharmaceutical Co's Forward PE Ratio, along with its competitors' market caps and Forward PE Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Kobayashi Pharmaceutical Co Forward PE Ratio vs Consumer Packaged Goods Industry
For the Consumer Packaged Goods industry and Consumer Defensive sector, Kobayashi Pharmaceutical Co's Forward PE Ratio distribution charts can be found below:
* The bar in red indicates where Kobayashi Pharmaceutical Co's Forward PE Ratio falls into.
Kobayashi Pharmaceutical Co Forward PE Ratio Calculation
It's a measure of the price-to-earnings ratio (PE Ratio) using forecasted earnings for the calculation. While the earnings used are just an estimate and are not as reliable as current earnings data, there is still benefit in estimated P/E analysis. The forecasted earnings used in the formula can either be for the next 12 months or for the next full-year fiscal period.
Kobayashi Pharmaceutical Co (FRA:KOY) has a Forward PE Ratio of 37.94 as of Jul. 22, 2026. Forward P/E ratio is the share price dividend by the expected per-share earnings in the next 12 months. View historical data on Kobayashi Pharmaceutical Co and its competitors. According to the industry distribution chart, Kobayashi Pharmaceutical Co ranks #680 out of 745 companies in the Consumer Packaged Goods industry, placing it in the top 91.3%.
Is Kobayashi Pharmaceutical Co's Forward PE Ratio too high?
Kobayashi Pharmaceutical Co's current Forward PE Ratio is 37.94. The Consumer Packaged Goods industry median Forward PE Ratio is 14.35. Kobayashi Pharmaceutical Co's value of 37.94 is 164.4% above this industry median. Based on the distribution chart, Kobayashi Pharmaceutical Co ranks #680 out of 745 companies in the Consumer Packaged Goods industry, which is in the bottom quartile relative to peers. Overall, Kobayashi Pharmaceutical Co has a GF Score™ of 81/100, reflecting its overall financial health beyond just this single metric.
How does Kobayashi Pharmaceutical Co's Forward PE Ratio compare to PG and CL?
According to the Consumer Packaged Goods industry distribution chart, Kobayashi Pharmaceutical Co ranks #680 out of 745 companies for Forward PE Ratio. This places Kobayashi Pharmaceutical Co in the lower half of its industry. The industry median Forward PE Ratio is 14.35. Kobayashi Pharmaceutical Co's value of 37.94 is 164.4% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Forward PE Ratio for a Consumer Packaged Goods company?
The median Forward PE Ratio among Consumer Packaged Goods companies is 14.35, based on 745 companies in the industry. Companies in the top quartile (top 25%) have a Forward PE Ratio significantly above this median, while those in the bottom quartile fall well below. However, Forward PE Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Kobayashi Pharmaceutical Co's current Forward PE Ratio of 37.94 is 164.4% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Forward PE Ratio mean?
A high Forward PE Ratio can signal that a stock is expensive relative to its fundamentals. Forward P/E ratio is the share price dividend by the expected per-share earnings in the next 12 months. View historical data on Kobayashi Pharmaceutical Co and its competitors. For the Consumer Packaged Goods industry, the median Forward PE Ratio is 14.35 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Kobayashi Pharmaceutical Co's current Forward PE Ratio is 37.94. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Kobayashi Pharmaceutical Co stock overvalued right now?
Kobayashi Pharmaceutical Co (FRA:KOY) has a current Forward PE Ratio of 37.94. The stock's GF Value™ is €30.01, compared to a current price of €28.40 — trading 5.4% below its estimated fair value. The current Forward PE Ratio is 37.94 and 164.4% above the Consumer Packaged Goods industry median of 14.35. Kobayashi Pharmaceutical Co's overall GF Score™ is 81/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Forward PE Ratio calculated?
Forward PE Ratio is calculated from a company's financial statements. For Kobayashi Pharmaceutical Co (FRA:KOY), the current Forward PE Ratio is 37.94 as of Jul. 22, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Kobayashi Pharmaceutical Co (FRA:KOY) Overvalued in 2026?
Based on GuruFocus' analysis, Kobayashi Pharmaceutical Co stock appears to be undervalued.
The current stock price of €28.40 is trading 5.4% below its estimated GF Value™ of €30.01.
Key valuation signals for FRA:KOY:
Forward PE Ratio: 37.94
GF Value™: €30.01 vs. price of €28.40 (5.4% below fair value)
Industry Position: 164.4% above the Consumer Packaged Goods median (#680 of 745)
No single metric tells the full story. See the FRA:KOY stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Kobayashi Pharmaceutical Co Ltd is engaged in the manufacture and sale of healthcare products, daily necessities, and body warmers. The company operates through two reportable segments: Domestic Business and International Business, which handle production and sales activities in Japan and overseas, respectively. The company's product portfolio includes disposable body warmers, cooling gel sheets, OTC pharmaceuticals, oral hygiene products, air fresheners, eyeglass wipes, and deodorizing/household sundries.
81GF Score
Get the complete analysis for FRA:KOY
Forward PE Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:KOY has been successfully added to your 
